Bringing the fundamentals into focus…
Back to Xeris Biopharma Holdings, Inc.
How Xeris Biopharma Holdings, Inc. stacks up
XERS · against 454 other Healthcare companies listed in US-listed
Growth
85/ 100
Above the middle of the pack.
Ranked #110 of 455 · scores higher than 75% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including XERS · Click a bar to see the companies
Why growth scores 85?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 88% of peers. Revenue growth: 36.3% vs peer median 6.1%
- faster revenue growth over three years: stronger than 90% of peers. 3-year revenue growth: 35.8% vs peer median 5.8%
Metric by metric
Position: dot = XERS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 36.3% | 11.0% | 78% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 35.8% | 11.0% | 81% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around XERS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 110 | 10.7B USD | 85 | 78 | |
| 110 | 5.1B USD | 85 | 52 | |
| 110 | 303M USD | 85 | 27 | |
| 110 | 513M USD | 85 | 31 | |
| 110 | 1.9B USD | 85 | 47 | |
| 116 | 3.9B USD | 84 | 47 | |
| 116 | 222M USD | 84 | 31 | |
| 116 | 1.1B USD | 84 | 50 | |
| 116 | 4.6B USD | 84 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score